China Starch Holdings Limited disclosed that its issued share capital remained unchanged at 5.96 billion ordinary shares as of 23 June 2026, while intensifying its on-market buyback programme.
Key details 1. Latest transaction: On 23 June 2026 the company repurchased 8.00 million shares on the Hong Kong Stock Exchange at prices ranging between HKD 0.147 and HKD 0.155, for a total consideration of HKD 1.21 million. All shares are designated for cancellation.
2. Cumulative repurchases awaiting cancellation: From 24 March to 23 June 2026, 69.47 million shares have been bought but not yet cancelled, equivalent to approximately 1.16 % of the current issued share base. Purchase prices during this period ranged from HKD 0.1651 to HKD 0.1893 per share, with the most recent trade executed at a lower band of HKD 0.147–0.155.
3. Mandate utilisation: The existing shareholder mandate, approved on 12 May 2026, authorises the repurchase of up to 596.45 million shares. To date, 45.57 million shares, or 0.76 % of the company’s share capital at the mandate date, have been repurchased under this authority, leaving around 92 % of the mandate unutilised.
4. Moratorium: In accordance with Hong Kong Listing Rules, the company is restricted from issuing new shares or disposing of treasury shares until 23 July 2026, 30 days after the latest repurchase.
The disclosure underscores China Starch’s continued focus on capital management through systematic share buybacks, with a substantial portion of its approved mandate still available for future repurchases.
Comments